Boundless Bio, Inc.BOLDNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank71
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-47.21M
↑ 25% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-62.67M
Historical baseline
PeriodValueYoY Change
TTM$-47.21M+25.5%
2024$-63.38M-33.5%
2023$-47.49M-16.8%
2022$-40.66M-60.8%
2021$-25.28M+78.9%
2018$-119.59M-29.9%
2017$-92.06M-40.2%
2016$-65.67M-